首页> 美国卫生研究院文献>Frontiers in Immunology >Strategies for Building Reference Standards for Autoantibodies
【2h】

Strategies for Building Reference Standards for Autoantibodies

机译:建立自身抗体参考标准的策略

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Producing robust, certified, traceable reference material for autoantibody testing is a vital element in maintaining the validity of results that are generated in the daily clinical laboratory routine. This is a huge challenge because of the high number of variables involved in the detection and measurement of the autoantibodies. The production of such materials is time consuming and needs rigorous attention to detail; this is best achieved by an overarching independent body who will oversee the process in a “not for profit” manner. Much effort has been made to build international standards for quantitative and qualitative assays based on monoclonal antibodies, obtained from affinity purification and plasmapheresis. The big challenge is to respect individual differences in immune response to the same antigen. A promising ongoing initiative is the construction of pools with monospecific samples from different individuals.
机译:生产坚固,经过认证的可追溯参考物质用于自身抗体测试,对于维持日常临床实验室程序中产生的结果的有效性至关重要。这是一个巨大的挑战,因为自身抗体的检测和测量涉及大量变量。此类材料的生产非常耗时,并且需要对细节进行严格的关注。最好由一个独立的总体机构来实现,该机构将以“非牟利”的方式监督该过程。为了建立基于单克隆抗体的定量和定性测定的国际标准,已经做出了很多努力,这些标准是从亲和纯化和血浆置换获得的。最大的挑战是要尊重针对同一抗原的免疫反应的个体差异。正在进行的一项有前途的举措是用不同个体的单特异性样品构建池。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号